4.5 Letter

Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria

Related references

Note: Only part of the references are listed.
Article Microbiology

Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B

Maria Helena Rigatto et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Article Infectious Diseases

Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes

Ki Hwan Kwon et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)

Article Infectious Diseases

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

Felipe F. Tuon et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)

Article Infectious Diseases

Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit

Matthaios Papadimitriou-Olivgeris et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)

Article Infectious Diseases

Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission

Matthaios Papadimitriou-Olivgeris et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Article Transplantation

A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients

Sean M. Bagshaw et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)